TNFRSF9 and leukemia: In hematologic malignancies, it has been shown that the expression and signaling of 4-1BB and its ligand, 4-1BBL, on T and B leukemia cells enhance the proliferation and survival of the malignant cells as well as promote drug resistance (43).